ROBERT H. WIER, M.D.; JOHN C. EAGAN, M.D.; SAMUEL A. WOLFSON, M.D.
This content is PDF only. Please click on the PDF icon to access.
It is generally agreed that the sedimentation rate of the erythrocytes is a valuable guide in the management of patients in a number of disease states, among which is coronary artery disease with myocardial infarction. Therefore, any form of therapy which could influence the rate would neutralize its value and thus deprive the physician of an excellent gauge of recovery. Such a possibility became apparent when Dicumarol was suggested in the treatment of myocardial infarction.
In 1942 Allen, Barker and Waugh1 stated that Dicumarol increased the sedimentation rate of the erythrocytes. However, in that same year, Wright and Prandoni2 were
WIER RH, EAGAN JC, WOLFSON SA. THE EFFECT OF DICUMAROL ON THE ERYTHROCYTE SEDIMENTATION RATE1. Ann Intern Med. 1950;33:354–360. doi: 10.7326/0003-4819-33-2-354
Download citation file:
Published: Ann Intern Med. 1950;33(2):354-360.
Cardiology, Hospital Medicine.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use